Amino acid (AA)-related inherited metabolic disorders (IMDs) and urea cycle disorders (UCDs) require strict dietary management including foods low in protein such as fruits, vegetables and starchy roots. Despite this recommendation, there are limited data on the AA content of many of these foods. The aim of this study is to describe an analysis of the protein and AA content of a range of fruits, vegetables and starchy roots, specifically focusing on amino acids (AAs) relevant to AA-related IMDs such as phenylalanine (Phe), methionine (Met), leucine (Leu), lysine (Lys) and tyrosine (Tyr). AA analysis was performed using high-performance liquid chromatography (HPLC) on 165 food samples. Protein analysis was also carried out using the Dumas method. Foods were classified as either ‘Fruits’, ‘Dried fruits’, ‘Cruciferous vegetables’, ‘Legumes’, ‘Other vegetables’ or ‘Starchy roots’. ‘Dried fruits’ and ‘Legumes’ had the highest median values of protein, while ‘Fruits’ and ‘Cruciferous vegetables’ contained the lowest median results. ‘Legumes’ contained the highest and ‘Fruits’ had the lowest median values for all five AAs. Variations were seen in AA content for individual foods. The results presented in this study provide useful data on the protein and AA content of fruits, vegetables and starchy roots which can be used in clinical practice. This further expansion of the current literature will help to improve diet quality and metabolic control among individuals with AA-related IMDs and UCDs.
Mitochondrial methionyl‐tRNA formyltransferase (MTFMT) is required for the initiation of translation in mitochondria. Pathogenic variants in MTFMT have been described in association with clinical presentations with Leigh syndrome, as well with as multisystem involvement (particularly cardiac and ocular involvement). There is a spectrum of severity, but many reported presentations have been milder with a better prognosis than other pathogenic variants associated with Leigh syndrome. We describe the case of a 9‐year‐old boy homozygous for a pathogenic MTFMT variant (c.626C > T/p.Ser209Leu) who presented with hypertensive crisis on a background of hyperphagia and visual impairment. His clinical course was complicated by supraventricular tachycardia and severe autonomic instability, requiring intensive care unit admission. He also developed seizures, neurogenic bladder and bowel and had a markedly abnormal eye examination with bilateral optic atrophy. Magnetic resonance image brain showed abnormal high T2/fluid‐attenuated inversion recovery signal within the dorsal brainstem and in the right globus pallidus with some reduced diffusivity. Despite recovery from the acute neurological and cardiac manifestations, he has ongoing deficits in his gross motor skills and continues to have hyperphagia with rapid weight gain (approx. 20 kg in 2 years). Ophthalmic findings are persistent. This case expands the phenotype associated with MTFMT disease.
Communication of screen-positive newborn bloodspot screening (NBS) results is inherently challenging for both parents and HCPs. There is no internationally accepted gold-standard model, with heterogeneity in practice and with many jurisdictions reporting suboptimal parent and HCP experience. This service evaluation aimed to assess the model for communication of initial screen positive results for metabolic conditions through the Irish National Newborn Bloodspot Screening Programme (NNBSP). Under the current model, screen-positive results are communicated to parents by a healthcare professional (HCP) (usually over the phone) and follow-up is arranged through the maternity hospital of birth. The evaluation required engagement with three cohorts, comprising two parent cohorts (a True Positive (TP) cohort and a False Positive (FP) cohort) and one HCP cohort. A separate survey was designed for each cohort, informed by a review of the international literature and subject matter expertise. Overall, our evaluation found that the current model for communication of screen-positive results is acceptable to HCPs, the majority of whom regard communicating these results as an appropriate part of their role (61%) and feel confident doing so (68%). However, many parents reported that they did not receive key information, and 70% wanted more information at this first communication. Parents wanted clear, reassuring, and actionable information, including details of the suspected condition, next steps, and where to seek further support. HCPs wanted additional resources to support communication of screen-positive results, including guidelines, expert contacts, condition-specific information resources, and checklists. The findings of this evaluation will inform revisions of the current model, aimed at ensuring a better experience for parents and HCPs.
Metabolic myopathies (MMs) are a group of genetic disorders causing muscle weakness, exercise intolerance and rhabdomyolysis due to impaired energy metabolism. Children with MMs often struggle to participate in exercise programs due to deconditioning, fatigability, lack of access, or other barriers, such as anxiety related to symptoms associated with physical activity. This study assessed a tailored at-home exercise program with one-on-one supervision for children with MMs, focusing on muscle strength, cardiovascular fitness and quality of life (QOL). The exercises focused on anaerobic strength training of limb girdle and core musculature. The study visits and intervention were well-received and completed by all participants. Rate of perceived exertion (RPE) and fatigue perception were kept consistent throughout the study, with a steady increase in training volume, as the intervention progressed. QOL as assessed by PedsQLTM varied between participants and their parents, but did not reflect the changes in exercise tolerance. Analysis of body composition with dual energy X-ray absorptiometry (DEXA) demonstrated increase in percentage lean mass, reduction in percentage fat mass and reduction in visceral adipose tissue for all participants post-intervention. All participants expressed an intention to continue the training program post-study. This study demonstrated the feasibility and potential benefits of a structured and supervised, at-home exercise program in children with MMs. A longer-term study of the intervention is warranted to determine long term effects on QOL and other parameters.